NCI National Cancer Institute www.cancer.gov U.S. National Institutes of Health
from the office of Deborah Winn, Pd.D., Acting Associate Director EGRP

EGRP Bulletins


EGRP Research Highlights PDF version

2002 and Prior News Flashes and Bulletins

*News Flash, December 31, 2002

Receipt date changed for RFA for Breast Cancer and the Environment Research Centers

The deadline for receipt of applications submitted in response to the Request for Applications (RFA) for Breast Cancer and the Environment Research Centers has been extended to April 14, 2003. The date had been February 11. The date for receipt of letters of intent is changed to March 14. This RFA is cosponsored by the National Institute of Environmental Health Sciences (NIEHS) and the National Cancer Institute (NCI).

Notice, NOT-ES-03-006, of the change appeared in the NIH Guide for Grants and
Contracts, release date December 30, 2002. All other aspects of the RFA remain unchanged.

You also may be interested in viewing information from a pre-application meeting that was held in mid-December. Visit NIEHS' Web site to access the print materials and video. The RFA, ES-03-001, appeared in the NIH Guide, release date November 11, 2002.

Please direct inquiries about the RFA to NIEHS Program Director Gwen Collman, Ph.D., or NCI Program Director Kumiko Iwamoto, M.D., Dr.P.H.

The staff of the Epidemiology and Genetics Research Program wish you a happy
and successful new year.

*News Flash, December 9, 2002

We let you know recently about a Request for Applications (RFA) to establish breast cancer and the environment centers that is being cosponsored by the National Institute of Environmental Health Sciences (NIEHS) and the National Cancer Institute (NCI). A pre-application meeting is set for Friday, December 13, for investigators who are planning to submit applications in response to the RFA. Notice of the meeting, NOT-ES-03-004, appears in the NIH Guide for Grants and Contracts.

Please refer to the Notice for further information about the meeting, which will be held in Research Triangle Park, N.C., including availability of a real-time Internet simulcast and names of contacts. On-site attendees must register on-line by Wednesday, December 11, and NIEHS would appreciate hearing in advance about interest among others in the simulcast.

Letters of intent for the RFA are due December 31, and applications are due February 11, 2003.

*News Flash, November 25, 2002

New Request for Applications and Other Funding Opportunities:

*News Flash, July 19, 2002

Trapido Appointed Associate Director of Epidemiology and Genetics Research Program

The National Cancer Institute (NCI) has appointed Edward Trapido, Sc.D. (photo), of the University of Miami School of Medicine, to be the new Associate Director of the Epidemiology and Genetics Research Program (EGRP), Division of Cancer Control and Population Sciences (DCCPS). Trapido will plan, direct, and manage NCI's extramural epidemiology and genetic epidemiology research program, which supports more than 400 research grants and cooperative agreements totaling $280 million. He will join NCI in September.

As Associate Director of EGRP, Trapido will have many opportunities to shape the direction of cancer epidemiology and genetics. He will oversee and further development of the Cancer Family Registries, Cancer Genetics Network, and the new Cohort Consortium, which are all multi-institutional infrastructures supporting modern cancer epidemiology. Among his challenges will be to stimulate and support research on gene-gene and gene-environment interactions, and to facilitate the development of research consortia able to conduct studies that require very large populations. He also will work to further new NCI initiatives to identify social determinants of cancer outcomes and cancer-related health disparities.

Trapido is Professor and Vice Chair of the Department of Epidemiology and Public Health, University of Miami School of Medicine. He also is Associate Director for Cancer Prevention and Control at the Sylvester Comprehensive Cancer Center, and directs the M.P.H. and Ph.D. Epidemiology Teaching Programs.

Principal investigator of several major cancer control research and education programs, Trapido directs the NCI Cancer Information Service, Florida Cancer Data System, Florida Comprehensive Cancer Control Initiative, and the Southeast Region of Redes En Action, which focuses on Hispanic cancer prevention and control activities. He also is Director of the Tobacco Research and Evaluation Coordinating Center and special consultant to the Florida Tobacco Pilot Program, which has received nationwide acclaim for reducing teenage smoking.

Before joining the University of Miami as an epidemiologist in 1984, Trapido was a staff fellow for three years in NCI’s intramural epidemiology program, which is the predecessor of today’s Division of Cancer Epidemiology and Genetics (DCEG). From 1977 to 1981, he was a research fellow and then a research associate in the Department of Epidemiology, Harvard School of Public Health.

He earned an M.S.P.H. in parasitology from the University of North Carolina at Chapel Hill in 1974, and holds Sc.M and Sc.D. degrees from Harvard University School of Public Health in 1981. He is a member of the American College of Epidemiology.

Until Trapido’s arrival, Deborah (Debbie) Winn, Ph.D., will continue to provide outstanding leadership as Acting Associate Director of EGRP.

*News Flash, May 30, 2002

Cancer Genetics Network: A Resource for Research on Genetic Basis of Human Cancer Susceptibility

The Cancer Genetics Network (CGN) is a resource available to support research on the genetic basis of human cancer susceptibility, the integration of this information into medical practice, and on the psychosocial, ethical, legal, and public health issues associated with human
genetics.

The CGN's interests include:

The growing database has information on 13,000 individuals (12,000 families) with cancer and/or a family history of cancer. Visit the CGN Web site at http://epi.grants.cancer.gov/CGN for more information about the enrollees.

Investigators who are interested in accessing the data or including registry enrollees in ongoing or proposed studies should prepare a 1-page description of their research to include the specific aims and an explanation of the role of CGN enrollees in the research. Research funding is not provided. Priority is given to funded investigators or to those who are planning to submit applications for National Institutes of Health grants.

Direct proposals and inquiries to:

Carol Kasten-Sportes, M.D.
Epidemiology and Genetics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
6130 Executive Blvd., Rm. 5136, MSC 7393
Rockville, MD 20892-7393
Phone: 301-402-8212 Fax: 301-435-5477
E-mail: kastenca@mail.nih.gov

*News Flash, May 8, 2002

Invitation to Comment on NIH Draft Statement on Sharing Research Data

The deadline for submitting comments about the National Institutes of Health's (NIH) draft statement on sharing of research data is June 1, 2002.

NIH is developing a statement on data sharing that expects and supports the timely release and sharing of final research data from NIH-supported studies for use by other researchers. Investigators submitting an NIH application will be required to include a plan for data sharing or to state why data sharing is not possible. This statement will apply to extramural scientists seeking grants, cooperative agreements, and contracts as well as intramural investigators.

Institutions and individuals are invited to comment on the draft policy. View additional information.

Comments must be received no later than June 1, 2002, and should be sent to:

Office of Extramural Research
1 Center Drive, MSC 0152
Building 1, Room 150
Bethesda, MD 20817

or by email to dder@nih.gov.

Following consideration of public comments and appropriate revisions, the new policy is expected to be announced on August 1, 2002, with a proposed effective date of January 1, 2003.

The announcement on the draft statement appeared in the NIH GUIDE FOR GRANTS AND CONTRACTS, March 1, 2002.

*News Flash, February 20, 2002

Myriad Genetics and NCI Renew Agreement on BRCA Gene Research Testing

Myriad Genetics, Inc., and the National Cancer Institute (NCI) have renewed their agreement in which the company will provide testing of the BRCA1 and BRCA2 genes at a reduced cost as a service to all National Institutes of Health (NIH) scientists and grantees. The agreement greatly reduces the cost of sequencing these genes in research protocols, allowing scientists to more aggressively pursue their investigations of these important cancer susceptibility genes. It applies to genetic testing for research purposes only, not the delivery of health care services to patients. The agreement makes it possible for researchers to obtain high-quality mutational analysis for research purposes at affordable prices.

*News Flash, February 1, 2002

Recent NCI Publications Released

The National Cancer Institute (NCI) recently released some publications that may be of interest:

*News Flash, December 18, 2001

Important Message to Investigators

Our Division has an important announcement about strict enforcement of the lead time for requesting prior acceptance of unsolicited applications of more than $500,000 in direct costs per year. NIH requires that grant applicants with a requested budget exceeding $500,000 in direct costs in any year contact the appropriate program staff member at least 6 weeks in advance of submitting the grant to the Center for Scientific Review (CSR) for peer review. If the requested dollar amount is greater than $1.5 million in direct costs in any year, then approval must be sought 8 weeks prior to submitting the grant to CSR for review. Please refer to the complete text of the announcement for more very important specifics.

New NIH Incoming Mail Address Requirements

The announcement also explains that grant applications for cohort studies over $500,000 in direct costs in any year must be submitted in response to NCI's Program Announcement for "Cohort Studies in Cancer Epidemiology" (PAS-02-009). The PAS was issued this past summer.

On a different note, NIH has new requirements for accepting incoming mail. Refer to the Notice for information about specific zip codes to use. Be especially aware that applications and other deliveries to CSR now must come either via courier delivery or the U.S. Postal Service. Applications delivered by individuals to CSR will no longer be accepted. (NOT-OD-02-012)

Our apologies if you've received more than one copy of this communication. We merged several address lists to send this message. Although the Listserv deleted duplicates, if we had more than one e-mail address for you, or had your name recorded in different ways (e.g., with and without middle initial), you may have received more than one message. We'll try to resolve the problem for future mailings, if you'll contact Ms. Linda Anderson and let her know the particulars about how your e-mails were addressed (E-mail: andersol2@mail.nih.gov; telephone: 301-435-4906).

*News Flash, December 6, 2001

Andrew von Eschenbach Named Director of NCI

President Bush announced today that Andrew C. von Eschenbach, M.D., will head the National Cancer Institute (NCI) at the National Institutes of Health (NIH) in Bethesda, Md.

*News Flash, October 22, 2001

Policy Updated About Acceptance of Applications Exceeding $500,000 Per Year

The National Institutes of Health (NIH) is updating its policy on the acceptance of applications requesting direct costs of $500,000 or more for any one year. Effective with the January 1, 2002 receipt dates, applicants must seek agreement to accept assignment from Institute/Center staff at least 6 weeks prior to the anticipated submission of any application requesting $500,000 or more in direct costs for any year.

A Notice (NOT OD 02 004) appeared in the NIH Guide for Grants and Contracts, release date: October 16, 2001.

*News Flash, October 16, 2001

Program Announcement Issued on Cohort Studies in Cancer Epidemiology

A new Program Announcement (PA) on Cohort Studies in Cancer Epidemiology (PAS 02 009) is published in the NIH Guide for Grants and Contracts, release date: October 11, 2001.

*News Flash, September 14, 2001

*News Flash, August 9, 2001

Deadline Extended to Aug. 30 for Supplements for Dissemination of Promising Cancer Control Interventions

The Division of Cancer Control and Population Sciences (DCCPS), National Cancer Institute (NCI), has extended the deadline to August 30, 2001, for applications received in response to a letter Request for Applications (RFA) for supplemental support for dissemination of promising cancer control interventions. The announcement also has been amended to permit submissions of supplemental applications within the last six months of the last year (including an unfunded extension year/no cost extension) of a currently active NCI intervention research R01, P01, P50, U01, or U19 award. Applications must be active (either funded or in an unfunded extension).

Access at the Division of Cancer Control and Population Sciences' Web site :

*News Flash, July 11, 2001

Message to Potential Applicants and Grantees About Cost Control Measures

Dr. Barbara Rimer, Director, Division of Cancer Control and Population Sciences (DCCPS), National Cancer Institute (NCI), writes in a message to potential grant applicants and grantees about Institute cost control measures and reasons for them. She also mentions plans to issue soon a Program Announcement for Cohort Studies in Cancer Epidemiology. Dr. Rimer's message is posted now on the Division's Web site.

*News Flash, June 14, 2001

Deadline Extended to Apply for NCI Associate Director, Epidemiology and Genetics Research Program

The deadline for receipt of applications for Associate Director of the Epidemiology and Genetics Research Program, Division of Cancer Control and Population Sciences (DCCPS), National Cancer Institute (NCI), has been extended to July 15, 2001.

The Division is seeking a visionary, experienced senior scientist to lead NCI’s extramural program in cancer epidemiology and genetics. Candidates should be recognized national experts in epidemiology with demonstrated leadership in the development and management of large, diverse interdisciplinary research programs. The Associate Director plays a vital role in the success of a complex research program that is central to the NCI mission and has substantial international visibility.

For more information on the position and where to submit a letter of interest and C.V., access http://epi.grants.cancer.gov/AD.html.

*News

Position Advertised for Associate Director, Epidemiology and Genetics Research Program

*News Flash, April 3, 2001

Round Two of Applications Sought for Geographic-based Research in Cancer Control and Epidemiology

*News Flash, March 28, 2001

EGRP Associate Director Obrams Departs NCI in Mid-April

*News Flash, March 2, 2001

  • RFA Issued on Providing Shared Resources for Scientists Not at NCI-Funded Cancer Centers
  • Revised NIH Grants Policy Statement Published

*News Flash, March 1, 2001

Message from NCI Director on FY 2001 Grant Funding Policy

*News Flash, March 1, 2001

NIH Will Accept Applications Delayed Due to the Earthquake in the Seattle Area

*News Flash, January 25, 2001

NIH Course on Human Research Protections Goes Online

*News Flash, January 9, 2001

NCI and NIEHS Cosponsoring RFA for Research on Exposure Assessment Methods for Epidemiologic Research on Cancer

*News Flash, January 8, 2001

Deadline Extended to Feb. 27 for Abstracts for 5th International AIDS Malignancy Conference, April 23-25, Bethesda, Md.

*News Flash, December 20, 2000

NIEHS Sponsors RFA for Community-Based Participatory Research in Environmental Health

*News Flash, November 2000

EGRP's offices moved, and we're now united in Executive Plaza North, 6130 Executive Boulevard, Bethesda, Md.

Our telephone numbers have not changed. The EGRP Office of the Director has a new fax number, but the fax numbers for the Analytic Epidemiology and Genetics Research Branch (AERB) and Clinical and Genetic Epidemiology Research Branch (CGERB) remain unchanged.

Our e-mail addresses continue to work, but the National Institutes of Health (NIH) recently changed to a new system, and we urge you to update your address book with our new addresses. Some e-mail messages have failed to arrive, and we think the system change is responsible. Refer to Staff Contacts for contact information for individual staff members.

*New Flash, September 21, 2000

This is a brief News Flash to let you know of several announcements from the National Cancer Institute (NCI) and National Institutes of Health (NIH) that may be of interest:

  • NCI To Give Special Attention to Funding Research in High-Priority Areas Beginning With Submissions for Oct. 1 Deadline
  • Supplemental Funding Available to Expand Access to Specimen Collections, Requests Due by Nov. 5
  • How to Locate Information on Modular Grants, Modifications Announced
  • DCCPS Newsletter on the Web
  • EGRP Contacts by Research Topics
  • EGRP's Listserv Open to Investigators

*News Flash, February 22, 1999

  • Our Website is now live
  • New Program Announcement "Molecular Epidemiology of Prostate Carcinogenesis" advertised
  • Deadline for applying for EGRP branch chiefs approaching

Last Updated: 27 Oct 2009

Division of Cancer Control and Population Sciences National Cancer Institute Department of Health and Human Services National Institutes of Health USA.gov